Search Results

Warning for antihypertensive drug?

• Authors : Kjeldsen, S E (AUTHOR)

Subjects: *CLINICAL trials; *DRUG labeling; *HEART failure

• Source: Lancet. 10/6/2001, Vol. 358 Issue 9288, p1181-1182. 2p.

Record details

Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial.

• Authors : Solomon, George M; Linnemann, Rachel W; Rich, Rachel

Subjects: CYSTIC fibrosis; CYSTIC fibrosis transmembrane conductance regulator; DRUG labeling

• Source: Lancet Respiratory Medicine; Dec2024, Vol. 12 Issue 12, p947-957, 11p

Record details

Give a drug a good name.

• Authors : Mehta, Dinesh K.¹ ; Aronson, Jeffrey K.²

Subjects: *DRUG labeling; *LABELING laws; *CONSUMER lawEUROPEAN Community

• Source: Lancet. 4/21/2007, Vol. 369 Issue 9570, p1326-1328. 3p.

Record details

Reduction of deaths after drug labelling for risk of Reye's syndrome.

• Authors : Casteels-Van Daele, M (AUTHOR)

Subjects: *DRUG labeling; ASPIRIN; REYE'S syndrome

• Source: Lancet. 1/9/1993, Vol. 341 Issue 8837, p118-119. 2p.

Record details

Prescribing off-label drugs for children: when will it change?

• Authors : The Lancet (AUTHOR)

Subjects: *CLINICS; *DRUG labeling; MEDICAL prescriptions

• Source: Lancet. Sep2019, Vol. 394 Issue 10204, p1114-1114. 1p.

Record details

A favourable (molecular) signal for personalised medicine.

Subjects: *DRUG labeling; ANTINEOPLASTIC agentsUNITED StatesUNITED States. Food & Drug Administration

• Source: Lancet. 1/3/2009, Vol. 373 Issue 9657, p2-2. 1/2p. 1 Color Photograph.

Record details

Antituberculous therapy and acute liver failure.

• Authors : Noble, A (AUTHOR)

Subjects: *DRUG labeling; ANTITUBERCULAR agents; HEPATIC encephalopathy

• Source: Lancet. 4/1/1995, Vol. 345 Issue 8953, p867-867. 1p.

Record details

Suspension of licence for intravenous omeprazole in Germany.

• Authors : Kimbel, K H (AUTHOR)

Subjects: *DRUG labeling; INTRAVENOUS injections; OMEPRAZOLEGERMANY

• Source: Lancet. 9/10/1994, Vol. 344 Issue 8924, p756-756. 1p.

Record details

Ototoxicity with azithromycin.

• Authors : Wallace, M R (AUTHOR); Miller, L K (AUTHOR); Nguyen, M T (AUTHOR)

Subjects: *DRUG labeling; DEAFNESS; MYCOBACTERIAL diseases

• Source: Lancet. 1/22/1994, Vol. 343 Issue 8891, p241-241. 1p.

Record details

Secrecy and product information.

• Authors : Kimbel, K H (AUTHOR)

Subjects: *DRUG labeling; *DISCLOSURE; ATTITUDE (Psychology)EUROPEAN Union

• Source: Lancet. 2/1/1992, Vol. 339 Issue 8788, p312-312. 1p.

Record details